Company Info
Phone(610) 816-6640
Year Established
2006
Ticker
NBRV
Exchange
NASDAQ
Contacts
Christopher NaftzgerInterim CEO & General Counsel
Daniel Dolan
CFO
Company Description
Nabriva Therapeutics is a commercial-stage biopharmaceutical company engaged in the development of novel antibiotics to treat serious infections.
